Anti-irritant and anti-inflammatory effects of glycerol and xylitol in sodium lauryl sulphate-induced acute irritation by Szél, Edit et al.
1 
 
Anti-irritant and anti-inflammatory effects of glycerol and xylitol in sodium lauryl 
sulfate-induced acute irritation 
Effects of polyols in irritant contact dermatitis 
E Szél1, H Polyánka2, K Szabó2, P Hartmann3, D Degovics1, B Balázs4, IB Németh1, C 
Korponyai1, E Csányi4, J Kaszaki3, S Dikstein5, K Nagy6, L Kemény1,2, G Erős1,7 
1Department of Dermatology and Allergology, University of Szeged 
2MTA SZTE Dermatological Research Group 
3Institute of Surgical Research, University of Szeged 
4Department of Pharmaceutical Technology, University of Szeged 
5Unit of Cell Pharmacology, Hebrew University 
6Department of Oral Surgery, University of Szeged 
7Department of Oral Biology and Experimental Dental Research, University of Szeged 
Text word count: 2915 
Number of tables: 2 
Number of figures: 9 
Corresponding author: 
Edit Szél, M.D. 
Department of Dermatology and Allergology, Faculty of Medicine, University of Szeged, 
Korányi fasor 6., H-6720, Szeged, Hungary 
Tel: +36-70-776-1104 
Fax: +36-62-545-954 
E-mail: szeledit@hotmail.com 
2 
 
Authors have no conflicts of interest to declare. 
3 
 
Abstract 
BACKGROUND: Glycerol is known to possess anti-irritant and hydrating properties and 
previous studies suggested that xylitol may also have similar effects. 
OBJECTIVE: Our aim was to study whether different concentrations of these polyols restore 
skin barrier function and soothe inflammation in sodium lauryl sulfate (SLS)-induced acute 
irritation. 
METHODS: The experiments were performed on male SKH-1 hairless mice. The skin of the 
dorsal region was exposed to SLS (5%) for 3h alone or together with 5% or 10% of glycerol, 
respectively. Further 2 groups received xylitol solutions (8.26% and 16.52%, respectively) 
using the same osmolarities, which were equivalent to those of the glycerol treatments. The 
control group was treated with purified water. Transepidermal water loss (TEWL) and skin 
hydration were determined. Microcirculatory parameters of inflammation were observed by 
means of intravital videomicroscopy (IVM). Furthermore, accumulation of neutrophil 
granulocytes and lymphocytes, the expression of inflammatory cytokines and SLS penetration 
were assessed, as well. 
RESULTS: Treatment with the 10% of glycerol and both concentrations of xylitol inhibited 
the SLS-induced elevation of TEWL, moderated the irritant-induced increase in dermal blood 
flow and in the number of leukocyte-endothelial interactions. All concentrations of the 
applied polyols improved hydration and prevented the accumulation of lymphocytes near the 
treatment site. At the mRNA level, neither glycerol nor xylitol influenced the expression of 
interleukin-1 alpha. However, expression of interleukin-1 beta was significantly decreased by 
the 10% glycerol treatment, while expression of tumor necrosis factor-alpha decreased upon 
the same treatment, as well as in response to xylitol. Higher polyol treatments decreased the 
SLS penetration to the deeper layers of the stratum corneum. 
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CONCLUSION: Both of the analyzed polyols exert considerable anti-irritant and anti-
inflammatory properties, but the effective concentration of xylitol is lower than that of 
glycerol. 
Keywords: glycerol; xylitol; sodium lauryl sulfate, acute irritation
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Introduction 
Irritant contact dermatitis (ICD) is a non-immunologic and non-specific inflammatory 
disorder of the skin that is caused by physical, mechanical or chemical challenges[1]. 
Irritation is accompanied by disruption of the barrier and dehydration of the uppermost layer 
of the skin. Hence, agents contributing to skin hydration and the maintenance of its 
homeostasis are required for treatment and prevention of ICD. Glycerol, applied in several 
external formulations, meets these requirements. This polyol exerts anti-irritant effect and acts 
as a humectant[2, 3]. Moreover, glycerol improves barrier function, hydrates the skin, 
stabilizes skin collagen and accelerates wound healing[4, 5]. All these raise the question 
whether structurally similar polyol molecules exhibit similar properties. Xylitol is a naturally 
occurring polyol, which is a widely used substitute of sugar. Recent studies indicated that 
xylitol can be utilized as humectant and moisturizer, as well[6, 7]. In our previous study we 
have shown that both glycerol and xylitol suppresses the 0.1% sodium lauryl sulfate (SLS)-
induced acute skin irritation[8]. However, it is not clear whether these polyols are able to 
provide protection against a more serious irritation. Despite their similar chemical structure, 
in vitro examinations suggest that glycerol and xylitol evoke different gene expression 
changes in keratinocytes. Glycerol was found to decrease the expression of human leukocyte 
antigen DR while xylitol increased filaggrin expression[9]. Currently, we have a lot of data on 
the effects of glycerol on the skin and its potential mechanism of action[5], but much less 
information is available on the applicability of xylitol. 
Our goal was to examine and compare the effects of different concentrations of glycerol and 
xylitol on skin barrier function, skin hydration, dermal microcirculation, increase our 
knowledge on the cellular and molecular factors of inflammation and SLS penetration using 
an animal model of skin irritation. 
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Materials and Methods 
Animals 
12-15-week-old male SKH-1 hairless mice were housed in plastic cages in a thermoneutral 
environment with a 12h light-dark cycle and had access to standard laboratory chow and 
water ad libitum. All interventions were in full accordance with the NIH guidelines and 
protocols were approved by the Ethical Committee for the Protection of Animals in Scientific 
Research at the University of Szeged (license number: V./145/2013). Animals were 
anesthetized with a mixture of ketamine (90 mg/kg body weight) and xylazine (25 mg/kg 
body weight) administered intraperitoneally. In the end of the experiments, mice were 
euthanized with an overdose of ketamine (300 mg/kg). 
Experimental design (Fig. 1) 
Mice were randomly allocated into six groups. Group 1 (n=23) served as a control treated 
with purified water. Group 2 (n=23) was exposed to a 5% solution of SLS. In group 3 (n=23), 
the solution applied to the skin contained SLS (5%) and glycerol of 5%. The animals of group 
4 (n=23) received a solution with SLS (5%) and xylitol of 8.26%. Group 5 (n=23) was treated 
with SLS (5%) and glycerol of 10%, while in group 6 (n=23), SLS (5%) and xylitol of 
16.52% were applied to the skin. SLS and the polyols were dissolved in purified water. 
Osmolarities of appropriate glycerol and xylitol solutions were equivalent. Groups and 
treatments are summarized in Table 1. In each group, 15 mice were randomly chosen for 
patch testing followed by attenuated total reflectance Fourier transformed infrared 
spectroscopy (ATR-FTIR) or determination of transepidermal water loss (TEWL) and skin 
hydration. After sacrificing the animals, the treated skin was excised and divided into two 
parts. One part was used to determine either myeloperoxidase (MPO) activity or the 
expression of inflammatory cytokines (interleukin-1 alpha and beta – IL-1α and IL-1ß, tumor 
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necrosis factor-alpha – TNF-α) by means of real time polymerase chain reaction (RT-PCR). 
Half of the remaining part was fixed in a solution of formaldehyde for routine histology and 
the other half was subjected to immunofluorescent staining. 
Dorsal skin fold chamber was implanted to the dorsal region of the other 8 mice in order to 
study the microcirculation. 
Patch testing 
In closed patch tests, extra-large Finn Chambers (diameter of 18 mm) and corresponding filter 
discs soaked with 120 µL of the test solutions were applied to the dorsal region for 3 hours 
using Scanpore tape. The relative humidity was 40-50% and the ambient temperature was 
kept at 20-22 °C. 
Combined tape stripping and ATR-FTIR experiments 
For the ATR-FTIR experiments, corneocytes were obtained with adhesive cellophane tape 
from the patch-tested mice dorsal region. This was repeated up to 25 strips recording an IR 
spectrum after each third tape strip. Every first tape with one strip was discarded because of 
the possibility of surface contamination. The untreated dorsal skin of mice was stripped and 
measured with the same method. ATR-FTIR spectra were recorded with an Avatar 330 FT-IR 
spectrometer equipped with a horizontal ATR crystal (ZnSe, 45°), between 4000 and 400 
cm−1, at an optical resolution of 4 cm−1. 64 scans were co-added and all spectral 
manipulations were performed by using Thermo Scientific's GRAMS/AI Suite software. In 
order to obtain a reference spectrum of the API, a KBr pellet containing 0.5 mg SLS was 
prepared and used. The spectra of the preparations were measured. The spectra of treated and 
untreated samples were also recorded. Each spectrum of the individual layers of the treated 
stratum corneum (SC) – containing three strips –  was corrected with the spectrum of the own 
untreated layer. To ensure that no absorbances from the skin itself are remaining and 
8 
 
interfering the results, spectra of untreated control skin samples were also subtracted from 
spectra of water treated control skin samples. No ATR correction was performed. 
Measurement of TEWL and skin hydration 
TEWL and hydration measurements were carried out before application of Finn Chambers 
and 15 min after their removal. TEWL was assessed with a Tewameter TM300 and skin 
hydration was determined with a Corneometer CM825. 
Implantation of dorsal skin fold chamber 
Eight mice of each group were implanted by dorsal skin fold chambers according to a 
previously described method[10]. After a 24-h recovery period, a filter disc with 120 µL of 
the test solution was applied to the non-wounded side and covered with a non-permeable film 
for 3h. 
Intravital videomicroscopy 
The microcirculation was visualized with a fluorescent intravital videomicroscope (Zeiss). 
The anesthetized mice received a retrobulbar injection of 2% fluorescein isothiocyanate-
labeled dextran and 0.2% rhodamine-6G in order to visualize microcirculation and to stain 
leukocytes. During examinations, the tissue was superfused with 37°C saline. The 
microcirculatory parameters were assessed quantitatively off-line by frame-to-frame analysis 
of the videotaped images. The red blood cell velocity (RBCV, µm/s) was measured in 4 
separate fields of view, in at least 6 capillaries. Leukocyte-endothelial cell interactions were 
analyzed within 5 postcapillary venules per animal. Adherent leukocytes were defined in each 
vessel segment as cells that did not move or detach from the endothelial lining within an 
observation period of 30s. 
Routine histology 
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The hematoxylin-eosin stained 3 µm thick coded sections were analyzed with Pannoramic 
Viewer software. Thickness of viable epidermis (stratum corneum not included) was 
measured at 20 different points of each section. 
Immunofluorescent staining for lymphocytes 
The 6 µm cryosections were stained with phycoerythrine conjugated rat-anti mouse CD3 
antibody in 1:20 dilution. Nuclear staining with 4´, 6-diamidino-2-phenylindole (DAPI, 1:100 
dilution, 10 min incubation) was also performed. The sections were examined with an 
AxioImager.Z1 microscope (Zeiss). Images of the sections were analyzed with ImageJ 
software. The number of CD3+ cells was referred to 50 basal keratinocytes. 
RT-PCR 
Total RNA was isolated using RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
instructions. For PCR, amplification was carried out in duplicates of a total volume of 20 µL 
per sample. Subsequent RT-PCR was performed to quantify transcript abundance using 
custom primer sets and the Universal Probe Library (Roche) with an iQ Supermix (Bio-Rad) 
in an LC480 real-time PCR machine (Roche). Relative quantification was carried out using 
the 2−∆∆CT method and β2-microglobuline as an endogenous control. 
Tissue MPO activity 
The activity of MPO, a marker of polymorphonuclear granulocyte accumulation in inflamed 
tissues, was measured by the method of Kuebler et al.[11]. The MPO activities of the samples 
were measured at 450 nm (UV-1601 spectrophotometer) and the data were referred to the 
protein content. 
Statistical analysis 
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Data analysis was performed with SigmaStat for Windows software. Differences among 
groups were analyzed with Kruskal-Wallis one-way analysis of variance on ranks, followed 
by Dunn method for pairwise multiple comparison. P<0.05 was considered statistically 
significant.
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Results 
TEWL displayed only slight changes in the purified water-treated control group, while 
exposure to SLS led to a significant elevation in TEWL and application of glycerol of 5% 
failed to prevent this alteration. Xylitol and glycerol at concentrations of 8.26% and 10%, 
respectively, improved barrier function. Xylitol of 16.52% restored TEWL values to the 
control levels after irritant treatment (Fig. 2). 
In skin hydration, neither purified water in the control group nor SLS alone resulted in a 
remarkable alteration. However, glycerol and xylitol at both concentrations significantly 
increased hydration as compared to control and SLS-treated groups (Fig. 3). 
SLS-induced inflammation led to a considerably faster local blood flow compared to the 
control animals. 10% glycerol and xylitol at both applied concentrations were found to be able 
to prevent the irritant-induced RBCV elevation (Fig. 4.(a)). 
The number of sticking leukocytes detected in the control group was relatively low, while the 
SLS-treated group was characterized by significantly more leukocyte-endothelial interactions. 
5% glycerol was able to partially decrease leukocyte sticking as compared to SLS-treated 
group. Xylitol, applied at both concentrations, as well as 10% glycerol treatment, effectively 
prevented leukocyte-endothelial interactions as compared to the control group (Fig. 4.(b)). 
Epidermal thickness decreased by the exposure to SLS. Both polyols at all applied 
concentrations increased epidermal thickness considerably as compared to control and SLS-
treated groups (Fig. 5). 
Addition of polyols to SLS prevented the elevation of lymphocyte number induced by the 
irritant (Fig. 6). 
Exposure to SLS led to an elevation in the mRNA expression of IL-1α but neither glycerol 
nor xylitol interfered with this alteration (data not shown). SLS-induced inflammation was 
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accompanied by a considerable elevation in IL-1ß mRNA expression level as compared to the 
control group, which was inhibited only by the 10% glycerol treatment (Fig. 7.(a)). 
mRNA expression of TNF-α was found to be significantly higher in SLS-treated group 
compared to control group. Again, 5% glycerol had no effect, whereas 10% glycerol and 
xylitol applied in both concentrations were effective (Fig. 7.(b)). 
Irritation with SLS also led to a considerable increase in MPO activity as compared to control 
group. Addition of the higher concentrations of the polyols to SLS effectively decreased the 
MPO activities (Fig. 8). 
ATR-FTIR spectroscopy revealed the most characteristic bond of SLS assigned to SO2 stretch 
(asymmetric) at 1220 cm-1 (Fig. 9)[12]. It was found that both lower concentration polyol 
treatments yet modified the SLS penetration, however, significant decrease in the SLS amount 
in the deeper layers was observed applying the higher polyol treatments (Table 2). 
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Discussion 
SLS-induced inflammation is one of the most widely applied models of skin irritation[13], 
however, concentration of the experimentally administered SLS is a pivotal question[14]. 
According to previous data, 5% of SLS is sufficient to evoke an inflammation with visible 
signs and to increase skin blood flow but does not induce epidermal necrosis[15]. In our 
experiment, 3-hour-exposure to 5% SLS leads to an elevation of TEWL, which may be 
explained by hyperhydration of the stratum corneum (SC) and possible disorganization of 
lipid bilayers[16]. On the basis of previous studies, it has been expected that glycerol is able 
to moderate the irritant-induced TEWL changes[17, 18]. An explanation of the beneficial 
effects of glycerol may be that it stabilizes the lipids in SC and changes the water binding 
ability of proteins and lipids[19, 20]. However, increase in water holding capacity of SC 
reaches a plateau when applied glycerol concentration is higher than 3% after irritant 
challenge[18]. 
Our present study has shown that 10% glycerol and the xylitol treatment prevented the TEWL 
elevation caused by the 5% SLS treatment. The reason why our findings differ from those of 
other studies may be because of differences in experimental setups. Atrux-Tallau et al. applied 
a considerably high concentration of SLS (10%), which may have resulted in such severe SC-
disruption that lipid-stabilizing effect of glycerol was not sufficient to sustain the barrier 
function[18]. However, according to our results, barrier damage induced by 5% SLS could be 
repaired by 10% glycerol. Another important difference is that we applied the polyols 
together with SLS, while the mentioned other studies used the glycerol after the irritation. 
In addition to glycerol, xylitol has been proven to be an effective anti-irritant when applied 
together with 0.1% of SLS[8]. In the present study, we provide evidence that xylitol can 
ameliorate a more serious inflammation, as well, and can exert its beneficial effect at a lower 
concentration compared to glycerol. Although it is difficult to predict the in vivo activity of 
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polyols on the basis of their chemical structure[21], efficacy of xylitol may originate in its 
water binding capacity. 
The results underline the moisturizer effect of both polyols in terms of other parameters, too. 
SC hydration was found to decrease considerably when the mouse skin was exposed to 10% 
of SLS[18], however, our results revealed that 5% of SLS did not significantly reduce 
hydration in mice and both glycerol and xylitol raised hydration values. Moreover, the 
moisturizing effect of the polyols affected not only the SC, but also the viable epidermis, as it 
is demonstrated by elevation of epidermal thickness. Beyond skin hydration[22], 
inflammation-related edema[23] may also lead to a thicker epidermis. In our experiments, 
increased TEWL levels were detected, which may explain the reduction in epidermal 
thickness after SLS-treatment. According to our observations, the higher loss of water seems 
to exceed inflammation-caused edema and the thicker epidermis in polyol-treated groups 
shows the hydrating effect of glycerol and xylitol. 
It is known that exposure to SLS is accompanied by increased dermal blood flow[15, 24]. 
SLS-induced elevation in RBCV was successfully moderated by 10% glycerol and both 
applied concentrations of xylitol. Glycerol may directly affect microcirculation: it has been 
reported that 100% anhydrous glycerol reduces blood flow velocity and vessel diameter of 
micro-vasculatures[25]. As glycerol we used was one magnitude lower than that in the 
mentioned study and application of polyols decreased not only dermal blood flow but also 
other indicators of inflammation, we presume that in this examination, decrease in RBCV in 
polyol-treated groups seems to originate in the anti-inflammatory activity of these 
compounds. 
MPO is a frequently examined marker in murine models of ICD[26-29]. Our results suggest 
that SLS-treatment resulted in a considerable accumulation of neutrophil granulocytes, which 
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was prevented by the application of polyols. Both IVM and MPO activity results confirmed 
that glycerol and xylitol can influence the neutrophilic activity in this model of irritation. 
Although lymphocyte accumulation is more characteristic of atopic or allergic contact 
dermatitis, irritation may also be accompanied by elevated number of lymphocytes in the skin. 
According to the available literature data, application of SLS induces T cell-dominated 
inflammatory response in mouse oral mucosa[30]. In line with these results, our previous 
study has also demonstrated that exposure to SLS can lead to lymphocyte accumulation in the 
skin of SKH-1 mice[31]. This study provides evidence that the applied polyols are able to 
reduce the number of lymphocytes at the irritation site. 
However, it is also necessary to characterize the impact of polyols on the cornerstone 
mediators of inflammatory response. Keratinocytes produce cytokines and chemokines (e.g. 
IL-1α, IL-1ß, TNF-α, IL-8) after irritant challenge. The cytokines activate other cell types 
(e.g. dendritic, Langerhans, endothelial cells) whose cytokine release recruits neutrophil 
granulocytes, macrophages, mast cells and lymphocytes[32]. TNF-α is of special importance 
because migration of both dendritic and Langerhans cells require this cytokine and IL-1ß is 
also essential for the activation of the latter cell type[33, 34]. In murine models, elevation of 
TNF-α and IL-1ß can be expected in response to SLS treatment[35]. Furthermore, IL-1α also 
contributes to the inflammatory response[36]. In this study, both glycerol and xylitol 
decreased the mRNA expression of IL-1ß and TNF-α, but had no effect on the IL-1α levels. 
These may explain their beneficial effects on cellular factors of inflammation, but the exact 
mechanism via which glycerol and xylitol affect the cytokine expression requires further 
examinations. 
Finally, as glycerol may reduce the average aqueous pore radius in the SC, hereby decreasing 
the penetration of irritants[37], one may presume that the anti-irritant and anti-inflammatory 
effects of glycerol and xylitol are just elucidated by the hampered penetration of SLS. 
16 
 
Therefore, the penetration characteristic of SLS in the presence of the polyols, with combined 
tape stripping and ATR-FTIR spectroscopy[38, 39] was also studied. SLS penetration to the 
deeper SC layers decreased significantly at higher polyol concentrations, which is a novel 
feature for xylitol. However, this result is not completely in accordance with the previous 
observed effects of polyols, where xylitol merely proved to be effective already at lower 
concentration. In addition, hydrating effects of polyols is independent from their action on 
SLS penetration. Therefore, mechanism of action of glycerol and xylitol in acute ICD is 
thought to be partially due to their inhibition on SLS penetration but other unknown 
mechanisms should also exist. 
In conclusion, glycerol and xylitol effectively maintain the barrier function of the skin in SLS-
induced acute irritation and are able to hydrate the epidermis and exhibit anti-inflammatory 
activities. They prevent the inflammation-related increase in dermal blood flow, diminish the 
accumulation of neutrophil granulocytes and lymphocytes, moderate the expression of 
inflammatory cytokines and SLS penetration. The effective concentration of xylitol is lower 
than that of glycerol. According to these results both polyols may contribute to the prevention 
of ICD.
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Figures 
Fig. 1: Experimental setup 
Fig. 2: Transepidermal water loss (TEWL) after exposure to purified water (contr.) (white 
box), sodium lauryl sulfate (SLS) (black box), SLS plus glycerol (Gl) at 5% (gray box) and 
10% (checked gray box) or to SLS plus xylitol (Xy) at 8.26% (striped box) and 16.52% 
(checked white box). Values are given as percentage referred to TEWL before treatments. The 
plots demonstrate median with 25th and 75th percentiles. #: p<0.05 vs control, §: p<0.05 vs 
SLS-treated group. 
Fig. 3: Changes in skin surface hydration in purified water-treated (white box), SLS-treated 
(black box), SLS+5% glycerol-treated (gray box), SLS+8.26% xylitol-treated (striped box), 
SLS+10% glycerol-treated (checked gray box) and SLS+16.52% xylitol-treated (checked 
white box) animals. Values are given as percentage referred to hydration before the 
treatments. The plots demonstrate median with 25th and 75th percentiles. #: p<0.05 vs control, 
§: p<0.05 vs SLS-treated group. 
Fig. 4 4.(a): Red blood cell velocity (RBCV) in dermal capillaries after 3h of treatment in 
groups 1-6. Values are given in µm/s, the plots demonstrate median with 25th and 75th 
percentiles. #: p<0.05 vs control, §: p<0.05 vs SLS-treated group. 4.(b): Number of adherent 
leukocytes in the dermal postcapillary venules after 3h of treatment. Cell numbers are referred 
to the area of vessel wall and given in (cell/mm2)*102. The plots demonstrate median with 
25th and 75th percentiles. #: p<0.05 vs control, §: p<0.05 vs SLS-treated group. 
Fig. 5: Photomicrographs of dorsal skin from groups 1-6 (hematoxylin-eosin staining). The 
graph shows the epidermal thickness in different groups (µm). 50x magnitude, scale bar 
represents 50 µm. Values are given as median with 25th and 75th percentiles. #: p<0.05 vs 
control, §: p<0.05 vs SLS-treated group. 
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Fig. 6: Presence of lymphocytes in the treated skin in groups 1-6 (DAPI-staining, 
lymphocytes appear red). The graph demonstrates the number of CD3+ lymphocytes referred 
to 50 basal keratinocytes. 10x magnitude, scale bar represents 100 µm. Values are given as 
median with 25th and 75th percentiles. #: p<0.05 vs control, §: p<0.05 vs SLS-treated group. 
Fig. 7 7.(a): Expression of IL-1ß mRNA after different treatments. Values are given as 
normalized relative expression. The plots demonstrate median values with 25th and 75th 
percentiles. #: p<0.05 vs control, §: p<0.05 vs SLS-treated group. 7.(b): Expression of TNF-α 
mRNA in groups 1-6. Values are given as normalized relative expression. The plots 
demonstrate median values with 25th and 75th percentiles. #: p<0.05 vs control, §: p<0.05 vs 
SLS-treated group. 
Fig. 8: Myeloperoxidase (MPO) activity in treated skin of different groups. Enzyme activity 
is referred to protein content and given as mU/mg protein. The plots demonstrate median 
values with 25th and 75th percentiles. #: p<0.05 vs control, §: p<0.05 vs SLS-treated group. 
Fig. 9: Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) 
spectra of the pure SLS, the 5% solution of SLS and the non-treated stratum corneum. 
Absorbance is given in arbitrary units as a function of the wavenumber. 
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Tables  
Group Applied agents and concentrations 
Group 1 Purified water 
Group 2 SLS (5%) 
Group 3 SLS (5%) + Glycerol (5%) 
Group 4 SLS (5%) + Xylitol (8.26%) 
Group 5 SLS (5%) + Glycerol (10%) 
Group 6 SLS (5%) + Xylitol (16.52%) 
Table 1: Study groups, applied agents and their concentration
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 Group 2 
(SLS 5%) 
Group 3 
(SLS + Glycerol 5%) 
Group 4 
(SLS + Xylitol 8.26%) 
Group 5 
(SLS + Glycerol 10%) 
Group 6 
(SLS + Xylitol 16.52%) 
Number 
of layers 
M 25p; 
75p 
M 25p; 
75p 
M 25p; 
75p 
M 25p; 
75p 
M 25p; 
75p 
1-4 0.0226 0.0137; 
0.0264 
0.0309 0.0187; 
0.0518 
0.0318 0.0181; 
0.0468 
0.0319 0.0161; 
0.0532 
0.0196 0.0134; 
0.0360 
5-8 0.0234 0.0140; 
0.0433 
0.0223 0.0122; 
0.0300 
0.0241 0.0149; 
0.0454 
0.00601 
* 
0.00143; 
0.0134 
0.000 
* 
0.000; 
0.0133 
Table 2 Intensities in the upper and lower layers of the treated stratum corneum (relative absorbance at 
1220 cm-1 SLS) 
Median values (M) with 25th and 75th percentiles (25p and 75p) of relative absorbance corresponding to the amount of SLS 
penetrated to the stratum corneum layers (1-4: upper layers, 5-8: lower layers) in the five groups. Group 2 was used as a 
positive control. * p<0.05 vs. SLS-treated group. 
 
